Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zepp Health (ZEPP) Short term Debt: 2016-2024

  • Zepp Health's Short term Debt rose 2376.51% to $41.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $41.9 million, marking a year-over-year increase of 2376.51%. This contributed to the annual value of $41.9 million for FY2024, which is 2376.51% up from last year.
  • According to the latest figures from Q4 2024, Zepp Health's Short term Debt is $41.9 million, which was up 2,376.51% from $1.7 million recorded in Q4 2023.
  • In the past 5 years, Zepp Health's Short term Debt ranged from a high of $77.3 million in Q4 2020 and a low of $1.7 million during Q4 2023.
  • Its 3-year average for Short term Debt is $39.3 million, with a median of $41.9 million in 2024.
  • Per our database at Business Quant, Zepp Health's Short term Debt surged by 3,546.58% in 2020 and then slumped by 97.72% in 2023.
  • Over the past 5 years, Zepp Health's Short term Debt (Quarterly) stood at $77.3 million in 2020, then dropped by 27.37% to $56.2 million in 2021, then soared by 32.14% to $74.2 million in 2022, then plummeted by 97.72% to $1.7 million in 2023, then surged by 2,376.51% to $41.9 million in 2024.
  • Its last three reported values are $41.9 million in Q4 2024, $1.7 million for Q4 2023, and $74.2 million during Q4 2022.